167 Followers on Owler

EyePoint

is a Massachusetts-based pharmaceutical company that discovers and develops ophthalmic therapeutics for the treatment of eye disorders... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

EyePoint

is a Massachusetts-based pharmaceutical company that discovers and develops ophthalmic therapeutics for the treatment of eye disorders... Read more
EyePoint President & CEO: Jay S. Duker

President & CEO

Jay S. Duker

CEO Approval Rating

82/100

1987

PublicNASDAQEYPT

Pharmaceuticals & Biotechnology
Pharmaceuticals
2834 NAICS listing

Annual Revenue
$43.3M
Employees
120
Funding
$938.2M
Acquisitions
2

News

Conference Presentation
Mar 27, 2025
Benzinga
EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
Funding
Nov 01, 2024
GlobalNewswire
EyePoint received $161M in Post-IPO Equity Funding

EyePoint Competitors

1Kodiak Sciences
2Ocular
3ONL Therapeutics
4Genentech
5Novartis
6Graybug
7Aerie
8AbbVie
9Regenxbio
10Adverum
Unlock 11 + competitors

Trending Companies